"Cytomegalovirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.
Descriptor ID |
D022482
|
MeSH Number(s) |
D20.215.894.899.120
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cytomegalovirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Cytomegalovirus Vaccines".
This graph shows the total number of publications written about "Cytomegalovirus Vaccines" by people in this website by year, and whether "Cytomegalovirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytomegalovirus Vaccines" by people in Profiles.
-
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. J Infect Dis. 2022 04 19; 225(8):1399-1410.
-
HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission. Proc Natl Acad Sci U S A. 2019 02 26; 116(9):3728-3733.
-
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector. Clin Vaccine Immunol. 2017 Jan; 24(1).
-
Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection. Vaccine. 2016 Apr 12; 34(17):1993-9.
-
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial. Vaccine. 2016 Jan 12; 34(3):313-9.
-
Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment. J Clin Virol. 2009 Dec; 46 Suppl 4:S1-5.